CFT7455, a novel IKZF1/3 degrader, demonstrates potent activity in peripheral and CNS models of NHL as a single agent or in combination with clinically approved agents.

Autor: Thomenius, M. J., Perino, S., Kirby, J., Agafonov, R., Chaturvedi, P., Eron, S., Good, A., Hart, J. A., He, M., Phillips, A., Proia, D. A., Henderson, J. A., Nasveschuk, C., Fisher, S. L., Pollock, R. M.
Předmět:
Zdroj: Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p550-551, 2p
Databáze: Complementary Index